HilleVax Files 2025 Proxy Statement
| Field | Detail |
|---|---|
| Company | Hillevax, Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
HilleVax DEF 14A filed. Annual meeting proxy details out.
AI Summary
HilleVax, Inc. filed its definitive proxy statement (DEF 14A) on April 30, 2025, for its annual meeting of stockholders. The filing covers the fiscal year ending December 31, 2024, and outlines the company's corporate governance and matters to be voted on by shareholders. The company is based in Boston, MA, and operates in the biological products sector.
Why It Matters
This filing provides shareholders with crucial information regarding the company's leadership, executive compensation, and voting matters, enabling informed participation in corporate decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material events or financial disclosures that would inherently increase risk.
Key Numbers
- 20250430 — Filing Date (The date the definitive proxy statement was filed with the SEC.)
- 20250623 — Report Date (The period for which the proxy statement is reporting.)
- 1231 — Fiscal Year End (Indicates the end of HilleVax's fiscal year.)
Key Players & Entities
- HilleVax, Inc. (company) — Registrant
- 0000950170-25-060580 (filing_id) — Accession Number
- 321 Harrison Ave, Suite 500 (address) — Company Business Address
- Boston, MA 02118 (address) — Company Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming annual or special meeting. It provides detailed information about the matters to be voted on, including director elections, executive compensation, and other corporate proposals.
When was HilleVax, Inc.'s fiscal year end?
HilleVax, Inc.'s fiscal year ends on December 31st, as indicated in the filing.
Where is HilleVax, Inc. located?
HilleVax, Inc. is located at 321 Harrison Ave, Suite 500, Boston, MA 02118.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 30, 2025.
What is the SIC code for HilleVax, Inc.?
The Standard Industrial Classification (SIC) code for HilleVax, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding HilleVax, Inc..